Correlation Between Seres Therapeutics and Structure Therapeutics
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Structure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Structure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and Structure Therapeutics American, you can compare the effects of market volatilities on Seres Therapeutics and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Structure Therapeutics.
Diversification Opportunities for Seres Therapeutics and Structure Therapeutics
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Seres and Structure is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Structure Therapeutics go up and down completely randomly.
Pair Corralation between Seres Therapeutics and Structure Therapeutics
Given the investment horizon of 90 days Seres Therapeutics is expected to generate 1.89 times more return on investment than Structure Therapeutics. However, Seres Therapeutics is 1.89 times more volatile than Structure Therapeutics American. It trades about 0.14 of its potential returns per unit of risk. Structure Therapeutics American is currently generating about -0.21 per unit of risk. If you would invest 82.00 in Seres Therapeutics on September 1, 2024 and sell it today you would earn a total of 16.00 from holding Seres Therapeutics or generate 19.51% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Seres Therapeutics vs. Structure Therapeutics America
Performance |
| Timeline |
| Seres Therapeutics |
| Structure Therapeutics |
Seres Therapeutics and Structure Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Seres Therapeutics and Structure Therapeutics
The main advantage of trading using opposite Seres Therapeutics and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.| Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
| Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |